Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
22.7M
-
Shares change
-
-1.81M
-
Total reported value, excl. options
-
$55.3M
-
Value change
-
-$1.27M
-
Put/Call ratio
-
0.55
-
Number of buys
-
38
-
Number of sells
-
-53
-
Price
-
$2.43
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q3 2025
122 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q3 2025.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.7M shares
of 53M outstanding shares and own 42.88% of the company stock.
Largest 10 shareholders include CAS Investment Partners, LLC (5.2M shares), VANGUARD GROUP INC (2.4M shares), BANK OF AMERICA CORP /DE/ (1.63M shares), KPS Global Asset Management UK Ltd (1.22M shares), 683 Capital Management, LLC (1.18M shares), WORLDLY PARTNERS MANAGEMENT, LLC (1.16M shares), Quinn Opportunity Partners LLC (1.1M shares), BlackRock, Inc. (972K shares), RBF Capital, LLC (800K shares), and JANE STREET GROUP, LLC (800K shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.